Are Inpatients With COVID-19 at Higher Risk of Venous Thromboembolism?
Is VTE risk unusually high in patients with COVID-19? To find out, researchers compared VTE incidence in inpatients with COVID-19 vs those with CAP.
Is VTE risk unusually high in patients with COVID-19? To find out, researchers compared VTE incidence in inpatients with COVID-19 vs those with CAP.
How does the duration of respiratory distress in severe COVID-19 pneumonia affect the need for invasive mechanical ventilation, mortality, and length of hospital stay?
Stroke-associated pneumonia research over the past 2 decades has yielded significant insight into SAP risk factors, diagnostic measures, and management strategies.
In this meta-analysis, researchers assessed the relationship between 4 infectious bacteria and the risk for ischemic stroke.
Researchers compared the effect of Gram stain-guided antibiotics with guideline-based antibiotics for the treatment of patients with ventilator-associated pneumonia.
Researchers assessed whether the increased risk for dementia observed among older adults diagnosed with bacterial pneumonia differs by causative pathogen.
How effective is the 13-valent pneumococcal conjugate vaccine in preventing pneumonia and lower respiratory tract infection hospitalizations in older adults?
How do mortality rates differ among patients with COPD admitted to the hospital for pneumonia and those admitted for an exacerbation of COPD?
Researchers evaluated the use of metatranscriptomic RNA sequencing for the epidemiologic surveillance of pneumonia pathogens in patients with HIV infection.
Acute myocarditis occurs in 2.4 per 1,000 patients hospitalized for COVID-19, according to a study published in the April 12 issue of Circulation.